Merck Strikes Damages Deal In Fosamax Bellwether Case

Law360, New York (September 18, 2012, 1:32 PM EDT) -- Merck & Co. Inc. has reached a confidential damages agreement in New York federal court with the estate of a Florida woman whose $8 million jury verdict in jawbone-death litigation over osteoporosis drug Fosamax was later overturned, an attorney for the plaintiff said Tuesday.

Timothy M. O'Brien, a lawyer for the estate of Shirley Boles, said the parties had reached a confidential stipulation on damages, which a Merck spokesman emphasizes is not a settlement, on Sept. 8. Boles won an $8 million jury verdict in June...
To view the full article, register now.